Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F Little

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Blood|April 14, 2011
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapyThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Blood|March 1, 2003
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biologyRichard F Little, Stefania Pittaluga, Nicole Grant, et al.
American Journal of Clinical Pathology|April 19, 2013
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseGirish Venkataraman, Thomas S Uldrick, Karen Aleman, et al.
Blood|November 1, 2013
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseMark N Polizzotto, Thomas S Uldrick, Victoria Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapyThomas S Uldrick, Kathleen M Wyvill, Pallavi Kumar, et al.
The Journal of Infectious Diseases|April 2, 2015
18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic ParametersMark N Polizzotto, Corina Millo, Thomas S Uldrick, et al.
Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Follicular LymphomaKami Maddocks, Paul M Barr, Bruce D Cheson, et al.
Clinical and Vaccine Immunology : CVI|June 11, 2010
Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detectionShixing Tang, Jiangqin Zhao, Aifeng Wang, et al.
The Journal of Infectious Diseases|January 1, 2003
A pilot study of cidofovir in patients with kaposi sarcomaRichard F Little, Florentino Merced-Galindez, Katherine Staskus, et al.
Journal of Immunological Methods|March 10, 2010
Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISAGeorgina L Mbisa, Wendell Miley, Christine J Gamache, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Blood|April 14, 2011
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapyThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Blood|March 1, 2003
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biologyRichard F Little, Stefania Pittaluga, Nicole Grant, et al.
American Journal of Clinical Pathology|April 19, 2013
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseGirish Venkataraman, Thomas S Uldrick, Karen Aleman, et al.
Blood|November 1, 2013
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseMark N Polizzotto, Thomas S Uldrick, Victoria Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapyThomas S Uldrick, Kathleen M Wyvill, Pallavi Kumar, et al.
The Journal of Infectious Diseases|April 2, 2015
18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic ParametersMark N Polizzotto, Corina Millo, Thomas S Uldrick, et al.
Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Follicular LymphomaKami Maddocks, Paul M Barr, Bruce D Cheson, et al.
Clinical and Vaccine Immunology : CVI|June 11, 2010
Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detectionShixing Tang, Jiangqin Zhao, Aifeng Wang, et al.
The Journal of Infectious Diseases|January 1, 2003
A pilot study of cidofovir in patients with kaposi sarcomaRichard F Little, Florentino Merced-Galindez, Katherine Staskus, et al.
Journal of Immunological Methods|March 10, 2010
Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISAGeorgina L Mbisa, Wendell Miley, Christine J Gamache, et al.
Pageof 13